Mumbai: Booster’s shot even though it is offered in several Western countries, it remains a debatable subject and has not been approved in India.
However, health workers had taken third shots in various hospitals in Mumbai, various sources were confirmed to TI.
Covishield has become an option for a booster dose, a hospital source said, adding that in some cases the eleventh dose has been taken from vaccine vaccines for that purpose.
The head of another hospital said in another case, the third dose was taken from a bottle that might have some of the remaining doses but did not have a taker at the end of the day immunization drive.
“Health workers have seen a breakthrough infection between colleagues and worried about the variant that appears,” he said.
However, Dr.
Pradeep Vyas, an additional principal (health), call it wrong enthusiasm, by saying the third dose can cause a life-threatening reaction in some cases.
“Let’s be scientific and not driven by emotions,” he said.
Suresh Kakani, Supplementary City Commissioner, said, “There is a possibility of an extra dose in each bottle being used for this.
If someone uses the extra dose, there is no need for any registration.
But my question to those who took it is how they know it is useful at all , “he said.
Globally, some countries have launched the third dose, especially for parents, and some for health workers.
NHS staff in England began to get booster shots on Thursday.
The US is likely to launch the third shot from September 20, while Israel has published the findings that at least 12 days after the booster dose, the level of infection that was confirmed was lower in the Booster group with a factor of 11.3 and severe disease levels lower than 19.5 time.
However, two leading US vaccine scientists have written in Lancet that there is no credible evidence that the efficacy of vaccines against severe covid reduced substantially from time to time.
Who has also asked rich countries to survive for Booster Shots because it can worsen the injustice of global vaccines.
The Indian Council of the Head of Medical Research Dr.
Balram Bhargava said on Thursday that getting full vaccination with two doses remained a priority.
“The antibody level only should not be measured.
One can have cellular immunity, antibody immunity, mucosal immunity and it continues.”